Bank of America
ANRO icon

Bank of America’s Alto Neuroscience ANRO Stock Holding History

Bank of America’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$577K Buy
25,677
+14,585
+131% +$270K ﹤0.01% 4818
2025
Q4 		$197K Buy
11,092
+10,968
+8,845% +$138K ﹤0.01% 5353
2025
Q3 		$498 Sell
124
-821
-87% -$2.72K ﹤0.01% 7590
2025
Q2 		$2.08K Sell
945
-10,913
-92% -$26K ﹤0.01% 7426
2025
Q1 		$25.6K Sell
11,858
-44,674
-79% -$160K ﹤0.01% 6904
2024
Q4 		$239K Buy
56,532
+22,007
+64% +$137K ﹤0.01% 6024
2024
Q3 		$395K Buy
34,525
+27,411
+385% +$335K ﹤0.01% 5636
2024
Q2 		$76K Sell
7,114
-5,787
-45% -$75.3K ﹤0.01% 6369
2024
Q1 		$198K Buy
+12,901
New +$202K ﹤0.01% 5888

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America's ANRO Position: Q1 2026 in Review

Bank of America increased its Alto Neuroscience (ANRO) stake by 131% in Q1 2026, buying an estimated $270K and bringing the position to 25,677 shares worth $577K. The position accounts for ﹤0.01% of the portfolio, ranked #4818.

Bank of America first reported a position in ANRO in Q1 2024 and has held it in 9 quarters since. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Bank of America held 25,677 shares of Alto Neuroscience worth $577K as of Q1 2026.
  • Bank of America bought 14,585 Alto Neuroscience shares in Q1 2026, an estimated $270K.
  • Alto Neuroscience made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4818 holding.
  • Bank of America first reported a position in Alto Neuroscience in Q1 2024 and has held it in 9 quarters since.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.